Vaccination-induced thrombocytopenia and thrombosis (VITT) and pre-VITT: Do not miss (or misdiagnose) the new member of the thrombotic thrombocytopenias family
- PMID: 36156870
- PMCID: PMC9491842
- DOI: 10.1093/ehjopen/oeac056
Vaccination-induced thrombocytopenia and thrombosis (VITT) and pre-VITT: Do not miss (or misdiagnose) the new member of the thrombotic thrombocytopenias family
Conflict of interest statement
Conflict of interest: None declared.
Figures
Comment in
- doi: 10.1093/ehjopen/oeac036
Similar articles
-
Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase.Stroke. 2022 Oct;53(10):3206-3210. doi: 10.1161/STROKEAHA.122.039575. Epub 2022 Sep 9. Stroke. 2022. PMID: 36082668 Free PMC article.
-
Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.Vaccine. 2023 May 11;41(20):3285-3291. doi: 10.1016/j.vaccine.2023.03.071. Epub 2023 Apr 19. Vaccine. 2023. PMID: 37085453
-
Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.Clin Imaging. 2022 Oct;90:63-70. doi: 10.1016/j.clinimag.2022.06.020. Epub 2022 Jul 15. Clin Imaging. 2022. PMID: 35926315 Free PMC article.
-
Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines.Front Cardiovasc Med. 2022 Sep 29;9:967926. doi: 10.3389/fcvm.2022.967926. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36247442 Free PMC article. Review.
-
Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.Int J Infect Dis. 2022 Jun;119:130-139. doi: 10.1016/j.ijid.2022.03.034. Epub 2022 Mar 24. Int J Infect Dis. 2022. PMID: 35339716 Free PMC article.
Cited by
-
Chronic Immune Thrombocytopenia Purpura Following COVID-19 Vaccination (ChAdOx1 -nCov-19): A Case Report With OneYear Follow-Up.Hosp Pharm. 2024 Oct;59(5):552-556. doi: 10.1177/00185787241245914. Epub 2024 Apr 27. Hosp Pharm. 2024. PMID: 39318737
-
Highlights from 2022 in EHJ Open.Eur Heart J Open. 2022 Dec 30;2(6):oeac084. doi: 10.1093/ehjopen/oeac084. eCollection 2022 Nov. Eur Heart J Open. 2022. PMID: 36600883 Free PMC article. No abstract available.
References
-
- Salih F, Kohler S, Schönborn L, Thiele T, Greinacher A, Endres M. Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway. Eur Heart J Open 2022;2:oeac036. - PMC - PubMed
-
- Douxfils J, Vayne C, Pouplard C, Lecompte T, Favresse J, Potier F, Gasser E, Mathieux V, Dogné JM, Gruel Y, Rollin J, Mullier F. Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins – a rational for monitoring immunoglobulin G levels. Haematologica 2021;106:3249–3252. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources